Mission of peptides & elephants
Combining peptide expertise
and in depth technical knowledge
peptides&elephants was established in 2001 by Dr. Oliver J. Kreuzer and fellow researchers from the German Institute of Human Nutrition in Potsdam and the Charité in Berlin.
Dr. Kreuzer has had a long-standing passion for peptides. His diploma thesis in Chemical Engineering already centered around automated peptide processing. He continued this focus at Evotec, where he started to create his first peptide synthesis robot. His doctoral thesis on hormone receptors then led him to explore the user side of peptide chemistry. Experienced in both fields and equipped with an entrepreneurial spirit, he and his colleagues established their own company, bringing to life the first high parallel peptide synthesizer.
This company‘s first patented product spurred a major development: It paved the way for super-fast peptide library screening concepts, which have been adapted by peptide CMOs worldwide for use in drug discovery and immune research.
Over the following decades, Dr. Kreuzer evolved into a distinguished peptide expert, acquiring an intimate understanding of every amino acid's unique chemical properties. Coupled with his in-depth technical expertise, he was able to bring to life another groundbreaking invention: the proprietary Ultrasonic Peptide Synthesis USPS® platform. This market-leading technology can synthesize 192 separate peptides in the astonishingly short span of eight hours.
USPS® Ultrasonic Peptide Synthesis
The market leading technology!
USPS® supplies a wide range of research projects with
high-quality peptides, particularly in the field of Immunology.
Examples are research projects for
- the discovery of new drugs
- the development of novel therapies and vaccines
- the establishment of new diagnostic and analytical methods
- fundamental research.